We obtained high-quality cardiac tissue-like constructs (CTLCs) by cultivating hiPSC-CMs on aligned nanofibers made of biodegradable polymer. We show that multi-layered and elongated CMs could promptly be organized at high density along aligned nanofibers, resulting in upregulated cardiac biomarkers and enhanced cardiac functions. When used for drug assessment, CTLCs were much more robust than the 2D conventional control. We used the CTLCs to simulate the repairing of disconnected and arrhythmia CMs in vitro. When used to repair injured rat hearts, the CTLCs showed excellent operability leading to favorable heart function recovery.
Researchers from the Institute for Integrated Cell-Material Sciences (iCeMS) of Kyoto University and the Department of Cardiovascular Surgery of Osaka University have developed effective and convenient Cardiac Tissue-Like Constructs (CTLCs) for repairing myocardial infarctions.
Cardiovascular diseases such as infarctions are the leading cause of death globally. A seriously injured heart cannot recover by itself, and heart transplants are the only effective treatment. However, the waiting list for transplants is extremely long. Previous researchers have also used cell transplant technologies to repair injured hearts, but these used CMs organized in two dimensions with a random, myofibril structure, which is different from natural heart tissue.
Dr. Li Liu and Prof. Yong Chen of iCeMS, together with Prof. Yoshiki Sawa of Osaka University and colleagues, selected a PLGA material approved by the FDA, and prepared biodegradable, aligned nanofibers for culturing CMs derived from hiPSCs, successfully creating organized and functional CTLCs.
They found that the CMs infiltrated and enveloped the nanofibers, showing elongation and high organization with upregulated expression of cardiac markers. Their CTLCs demonstrated more robust drug response compared with 2D CMs.
The team also used the CTLCs to simulate the repairing of disconnected and arrhythmia CMs. When used to repair injured rat hearts, the CTLCs showed excellent operability leading to favorable heart function recovery.
Future studies are now being planned to use CTLCs to repair injured hearts of larger animals, before advancing to clinical applications.
Learn more: Mending hearts in three dimensions
The Latest on: Repairing myocardial infarctions
- Slow Release of a Drug, TT-10, Improves Heart Attack Recoveryon November 24, 2021 at 8:29 pm
Release of TT-10 from nanoparticles improved heart function after a heart attack, accompanied by increased cardiomyocyte proliferation and smaller infarct size in a mouse model. A heart attack kills ...
- Study offers insights into post-MI fibrosison November 19, 2021 at 7:45 am
A study led by scientists at Victor Chang Cardiac Research Institute in Sydney, Australia, has shown that the transcription factor hypoxia-inducible factor 1 (HIF-1) suppresses harmful reactive oxygen ...
- Using mussel adhesive proteins for cardiac tissue regenerationon November 11, 2021 at 9:05 am
A POSTECH research team has developed a treatment for myocardial infarction using a MAP-based microneedle bandage that are attachable to the heart tissue. The research team constructed a ...
- Stem Cells in Cardiac Repairon November 8, 2021 at 4:00 pm
Although different stem cells are available for cardiac repair, the optimal stem cell ... transplantation into patients' hearts after myocardial infarction must be investigated systematically ...
- Heart attack symptoms: 'Waxy growths' on your skin that may be a deadly heart disease signon November 5, 2021 at 7:44 am
You could be at risk of a deadly heart attack - or myocardial infarction - if you find an unusual growth on your skin, it's been claimed. Heart attacks are caused by a lack of blood reaching the ...
- TCT 513: A Rare Case Of COVID Vaccine Induced Thrombosis And Thrombocytopenia (VITT) Leading To a ST Elevation Myocardial Infarction (STEMI)on November 5, 2021 at 12:14 am
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD is produced by the Cardiovascular Research Foundation (CRF). CRF is committed to igniting the ...
- Invasive Versus Medical Management in Patients With Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarctionon November 4, 2021 at 7:36 pm
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD is produced by the Cardiovascular Research Foundation (CRF). CRF is committed to igniting the ...
- Cells or Drugs? The Race to Regenerate the Hearton November 3, 2021 at 2:23 pm
Myocardial infarction, commonly known as a heart attack ... which in turn affect heart repair by reducing inflammation and stimulating the development of new heart muscle. That means stem-cell ...
- Myocardial Infarctionon October 17, 2021 at 5:01 pm
A large nationwide study based on all COVID-19 patients in Sweden performed at Umeå University, concludes that the risk of acute myocardial infarction and stroke is three-fold increased the first ...
- Factors Influencing Outcome after Open Surgical Repair of Juxtarenal Abdominal Aortic Aneurysmson October 15, 2021 at 5:00 pm
Postoperative complications including myocardial infarction and renal failure arose ... imaging criteria to undergo open juxtarenal AAA repair, appropriate intraoperative management guarantees ...
via Google News and Bing News
